BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15638891)

  • 1. The prevalence of renal cell carcinoma diagnosed at autopsy.
    Mindrup SR; Pierre JS; Dahmoush L; Konety BR
    BJU Int; 2005 Jan; 95(1):31-3. PubMed ID: 15638891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Renal cell carcinoma diagnosed at autopsy in Iceland 1971-2005].
    Jonsson A; Hardarson S; Petursdottir V; Palsdottir HB; Jonsson E; Einarsson GV; Gudbjartsson T
    Laeknabladid; 2008 Dec; 94(12):807-12. PubMed ID: 19182316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection, staging and clinical implications of renal cell carcinoma.
    Ghalayini IF; Bani-Hani IH
    Saudi Med J; 2003 Jan; 24(1):79-83. PubMed ID: 12590282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cell carcinoma: incidental detection and pathological staging.
    Siow WY; Yip SK; Ng LG; Tan PH; Cheng WS; Foo KT
    J R Coll Surg Edinb; 2000 Oct; 45(5):291-5. PubMed ID: 11077776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study.
    Beisland C; Talleraas O; Bakke A; Norstein J
    BJU Int; 2006 Apr; 97(4):698-702. PubMed ID: 16536756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal cell carcinoma in dialysis patients: a single center experience.
    Kojima Y; Takahara S; Miyake O; Nonomura N; Morimoto A; Mori H
    Int J Urol; 2006 Aug; 13(8):1045-8. PubMed ID: 16903927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney cancer in Sweden: a decrease in incidence and tumour stage, 1979 - 2001.
    Lyrdal D; Aldenborg F; Holmberg E; Peeker R; Lundstam S
    Scand J Urol; 2013 Aug; 47(4):302-10. PubMed ID: 23137102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal cell and transitional cell carcinoma in a Japanese population undergoing maintenance dialysis.
    Satoh S; Tsuchiya N; Habuchi T; Ishiyama T; Seimo K; Kato T
    J Urol; 2005 Nov; 174(5):1749-53. PubMed ID: 16217276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
    Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
    BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses.
    Gillett MD; Cheville JC; Karnes RJ; Lohse CM; Kwon ED; Leibovich BC; Zincke H; Blute ML
    J Urol; 2005 Jun; 173(6):1893-6. PubMed ID: 15879770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of incidental detection for survival of patients with renal cell carcinoma: results of population-based study of 701 patients.
    Gudbjartsson T; Thoroddsen A; Petursdottir V; Hardarson S; Magnusson J; Einarsson GV
    Urology; 2005 Dec; 66(6):1186-91. PubMed ID: 16360438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese dual-center experience with 176 consecutive patients.
    Fujii Y; Komai Y; Saito K; Iimura Y; Yonese J; Kawakami S; Ishikawa Y; Kumagai J; Kihara K; Fukui I
    Urology; 2008 Sep; 72(3):598-602. PubMed ID: 18649929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal cell carcinoma and end stage renal disease.
    Farivar-Mohseni H; Perlmutter AE; Wilson S; Shingleton WB; Bigler SA; Fowler JE
    J Urol; 2006 Jun; 175(6):2018-20; discussion 2021. PubMed ID: 16697788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pT1 substaging in renal cell carcinoma: validation of the 2002 TNM staging modification of malignant renal epithelial tumors.
    Salama ME; Guru K; Stricker H; Peterson E; Peabody J; Menon M; Amin MB; De Peralta-Venturina M
    J Urol; 2005 May; 173(5):1492-5. PubMed ID: 15821466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A population-based study of renal cell carcinoma and prostate cancer in the same patients.
    Barocas DA; Rabbani F; Scherr DS; Vaughan ED
    BJU Int; 2006 Jan; 97(1):33-6. PubMed ID: 16336324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidental renal tumours.
    Patard JJ
    Curr Opin Urol; 2009 Sep; 19(5):454-8. PubMed ID: 19571758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary nuclear matrix protein 22 for diagnosis of renal cell carcinoma.
    Kaya K; Ayan S; Gokce G; Kilicarslan H; Yildiz E; Gultekin EY
    Scand J Urol Nephrol; 2005; 39(1):25-9. PubMed ID: 15764267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The haphazard approach to the early detection of asymptomatic renal cancer: results from a contemporary executive health programme.
    Feldstein MS; Rhodes DJ; Parker AS; Orford RR; Castle EP
    BJU Int; 2009 Jul; 104(1):53-6. PubMed ID: 19154476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreasing size at diagnosis of stage 1 renal cell carcinoma: analysis from the National Cancer Data Base, 1993 to 2004.
    Cooperberg MR; Mallin K; Ritchey J; Villalta JD; Carroll PR; Kane CJ
    J Urol; 2008 Jun; 179(6):2131-5. PubMed ID: 18423754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of tumour-associated symptoms on the prognosis of patients with renal cell carcinoma.
    Kawaciuk I; Hyrsl L; Dusek P; Jarolim L; Schmidt M; Kaliska V; Chocholaty M; Vesely S
    Scand J Urol Nephrol; 2008; 42(5):406-11. PubMed ID: 18932106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.